Oxysterol generation and liver X receptor-dependent reverse cholesterol transport: Not all roads lead to Rome

Molecular and Cellular Endocrinology

Volumn 368, Issue 1-2, 2013, Pages 99-107

  Pannu, Parveer S ^a   Allahverdian, Sima ^a   Francis, Gordon A ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

ABCA1; Cholesterol; Liver X receptors; Lysosomal cholesterol storage diseases; Oxysterols; Reverse cholesterol transport

Indexed keywords

20,22 DIHYDROXYCHOLESTEROL; 22 HYDROXYCHOLESTEROL; 24 HYDROXYCHOLESTEROL; 24,25 EPOXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); DESMOSTEROL; LANOSTEROL SYNTHASE; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LOW DENSITY LIPOPROTEIN; OXYSTEROL; PHOSPHOLIPID TRANSFER PROTEIN; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ABCA1 GENE; ABCG1 GENE; ABCG5 GENE; ABCG8 GENE; ATHEROMA; CELL MIGRATION; CEREBROTENDINOUS XANTHOMATOSIS; CETP GENE; CHOLESTEROL TRANSPORT; CYP7A1 GENE; ENDOSOME; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE; GENE ACTIVATION; HOMEOSTASIS; HUMAN; LIPOGENESIS; LYSOSOME; NONHUMAN; PATHOGENESIS; PLTP GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SR B1 GENE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; ENDOSOMES; GENE EXPRESSION REGULATION; HUMANS; HYDROXYCHOLESTEROLS; LIPOPROTEINS, LDL; LYSOSOMES; ORPHAN NUCLEAR RECEPTORS;

EID: 84875261030     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.07.013     Document Type: Review

References (162)

1. Adighibe O., Arepalli S., Duckworth J., Hardy J., Wavrant-De Vrieze F. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. Neurobiol. Aging 2006, 27:1431-1434.
2. Alpy F., Stoeckel M.E., Dierich A., Escola J.M., Wendling C., Chenard M.P., Vanier M.T., Gruenberg J., Tomasetto C., Rio M.C. The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein. J. Biol. Chem. 2001, 276:4261-4269.
3. Aye I.L., Waddell B.J., Mark P.J., Keelan J.A. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity. Biochim. Biophys. Acta 2010, 1801:1013-1024.
4. Babiker A., Andersson O., Lindblom D., van der Linden J., Wiklund B., Lutjohann D., Diczfalusy U., Bjorkhem I. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 1999, 40:1417-1425.
5. Babiker A., Andersson O., Lund E., Xiu R.J., Deeb S., Reshef A., Leitersdorf E., Diczfalusy U., Bjorkhem I. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 1997, 272:26253-26261.
6. Babiker A., Dzeletovic S., Wiklund B., Pettersson N., Salonen J., Nyyssonen K., Eriksson M., Diczfalusy U., Bjorkhem I. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. Scand. J. Clin. Lab. Invest. 2005, 65:365-375.
7. Bai Q., Xu L., Kakiyama G., Runge-Morris M.A., Hylemon P.B., Yin L., Pandak W.M., Ren S. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 2011, 214:350-356.
8. Barbier O., Trottier J., Kaeding J., Caron P., Verreault M. Lipid-activated transcription factors control bile acid glucuronidation. Mol. Cell. Biochem. 2009, 326:3-8.
9. Barter P.J., Brewer H.B., Chapman M.J., Hennekens C.H., Rader D.J., Tall A.R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler. Thromb. Vac. Biol. 2003, 23:160-167.
10. Bauman D.R., Bitmansour A.D., McDonald J.G., Thompson B.M., Liang G., Russell D.W. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. USA 2009, 106:16764-16769.
11. Berginer V.M., Salen G., Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. New. Engl. J. Med. 1984, 311:1649-1652.
12. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 2006, 260:493-508.
13. Bjorkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.J., Duan C., Lund E. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA 1994, 91:8592-8596.
14. Bjorkhem, I., Boberg, K. M., Leitersdorf, E., 2001 In: Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W. Vogelstein, B. (Eds.), The metabolic and molecular bases of inherited disease, vol.2. McGraw-Hill, New York, pp. 2961-2988.
15. Bjorkhem I., Lutjohann D., Breuer O., Sakinis A., Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol. Chem. 1997, 272:30178-30184.
16. Boadu E., Nelson R.C., Francis G.A. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein. Biochim. Biophys. Acta 2012, 1821:396-404.
17. Borthwick F., Allen A.M., Taylor J.M., Graham A. Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype. Clin. Sci. 2010, 119:265-272.
18. Bowden K.L., Bilbey N.J., Bilawchuk L.M., Boadu E., Sidhu R., Ory D.S., Du H., Chan T., Francis G.A. Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. J. Biol. Chem. 2011, 286:30624-30635.
19. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
20. Brown A.J., Jessup W. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Aspects Med. 2009, 30:111-122.
21. Brown J.M., Yu L. Opposing gatekeepers of apical sterol transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-binding cassette transporters G5 and G8 (ABCG5/ABCG8). Immunol. Endocr. Metabol. Agents. Med. Chem. 2009, 9:18-29.
22. Brown M.S., Goldstein J.L. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J. Biol. Chem. 1974, 249:7306-7314.
23. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
24. Brown M.S., Goldstein J.L. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 2009, 50(Suppl.):S15-S27.
25. Buhman K.K., Chen H.C., Farese R.V. The enzymes of neutral lipid synthesis. J. Biol. Chem. 2001, 276:40369-40372.
26. Cali J.J., Hsieh C.L., Francke U., Russell D.W. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 1991, 266:7779-7783.
27. Cali J.J., Russell D.W. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J. Biol. Chem. 1991, 266:7774-7778.
28. Cavelier C., Lorenzi I., Rohrer L., von Eckardstein A. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim. Biophys. Acta 2006, 1761:655-666.
29. Chang T.Y., Chang C.C., Ohgami N., Yamauchi Y. Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 2006, 22:129-157.
30. Chang T.Y., Li B.L., Chang C.C., Urano Y. Acyl-coenzyme A: cholesterol acyltransferases. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1-E9.
31. Charman M., Kennedy B.E., Osborne N., Karten B. MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J. Lipid Res. 2010, 51:1023-1034.
32. Chen W., Chen G., Head D.L., Mangelsdorf D.J., Russell D.W. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 2007, 5:73-79.
33. Chiang J.Y. Bile acids: regulation of synthesis. J. Lipid Res. 2009, 50:1955-1966.
34. Chiang J.Y., Kimmel R., Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001, 262:257-265.
35. Choi H.Y., Karten B., Chan T., Vance J.E., Greer W.L., Heidenreich R.A., Garver W.S., Francis G.A. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J. Biol. Chem. 2003, 278:32569-32577.
36. Choi H.Y., Rahmani M., Wong B.W., Allahverdian S., McManus B.M., Pickering J.G., Chan T., Francis G.A. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 2009, 119:3223-3231.
37. Compagnone N.A., Bulfone A., Rubenstein J.L., Mellon S.H. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology 1995, 136:2689-2696.
38. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 2000, 275:28240-28245.
39. Curtiss L.K., Boisvert W.A. Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 2000, 11:243-251.
40. Diczfalusy U., Olofsson K.E., Carlsson A.M., Gong M., Golenbock D.T., Rooyackers O., Flaring U., Bjorkbacka H. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 2009, 50:2258-2264.
41. Donkin J.J., Stukas S., Hirsch-Reinshagen V., Namjoshi D., Wilkinson A., May S., Chan J., Fan J., Collins J., Wellington C.L. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice. J. Biol. Chem. 2010, 285:34144-34154.
42. Dzeletovic S., Breuer O., Lund E., Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 1995, 225:73-80.
43. Edwards P.A., Kennedy M.A., Mak P.A. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul. Pharmacol. 2002, 38:249-256.
44. Francis G.A. The complexity of HDL. Biochim. Biophys. Acta 2010, 1801:1286-1293.
45. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 2003, 65:261-311.
46. Frolov A., Zielinski S.E., Crowley J.R., Dudley-Rucker N., Schaffer J.E., Ory D.S. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. J. Biol. Chem. 2003, 278:25517-25525.
47. Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., Lund E.G. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 2001, 276:38378-38387.
48. Fujiyama J., Kuriyama M., Arima S., Shibata Y., Nagata K., Takenaga S., Tanaka H., Osame M. Atherogenic risk factors in cerebrotendinous xanthomatosis. Clin. Chim. Acta 1991, 200:1-11.
49. Garver W.S., Heidenreich R.A. The Niemann-Pick C proteins and trafficking of cholesterol through the late endosomal/lysosomal system. Curr. Mol. Med. 2002, 2:485-505.
50. Gill S., Chow R., Brown A.J. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 2008, 47:391-404.
51. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
52. Goldstein J.L., Brown M.S. The LDL receptor. Arterioscler. Thromb. Vac. Biol. 2009, 29:431-438.
53. Goldstein J.L., Dana S.E., Faust J.R., Beaudet A.L., Brown M.S. Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J. Biol. Chem. 1975, 250:8487-8495.
54. Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
55. Goodwin B., Watson M.A., Kim H., Miao J., Kemper J.K., Kliewer S.A. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol. Endocrinol. 2003, 17:386-394.
56. Guarneri P., Guarneri R., Cascio C., Pavasant P., Piccoli F., Papadopoulos V. Neurosteroidogenesis in rat retinas. J. Neurochem. 1994, 63:86-96.
57. Herzog B., Hallberg M., Seth A., Woods A., White R., Parker M.G. The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol. Endocrinol. 2007, 21:2687-2697.
58. Hoekstra M., Van Berkel T.J., Van Eck M. Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism. World J. Gastroenterol. 2010, 16:5916-5924.
59. Hu X., Li S., Wu J., Xia C., Lala D.S. Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 2003, 17:1019-1026.
60. Infante J., Rodriguez-Rodriguez E., Mateo I., Llorca J., Vazquez-Higuera J.L., Berciano J., Combarros O. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk. Neurobiol. Aging 2010, 31:710-714.
61. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
62. Javitt N.B. 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J. Lipid Res. 2002, 43:665-670.
63. Jiang Y.J., Lu B., Tarling E.J., Kim P., Man M.Q., Crumrine D., Edwards P.A., Elias P.M., Feingold K.R. Regulation of ABCG1 expression in human keratinocytes and murine epidermis. J. Lipid Res. 2010, 51:3185-3195.
64. Kandutsch A.A., Chen H.W. Inhibition of sterol synthesis in cultured mouse cells by cholesterol derivatives oxygenated in the side chain. J. Biol. Chem. 1974, 249:6057-6061.
65. Kase E.T., Andersen B., Nebb H.I., Rustan A.C., Thoresen G.H. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes. Biochim. Biophys. Acta 2006, 1761:1515-1522.
66. Katsuda S., Boyd H.C., Fligner C., Ross R., Gown A.M. Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am. J. Pathol. 1992, 140:907-914.
67. Kim W.S., Chan S.L., Hill A.F., Guillemin G.J., Garner B. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. J. Alzheimers Dis. 2009, 16:121-131.
68. Kim W.S., Rahmanto A.S., Kamili A., Rye K.A., Guillemin G.J., Gelissen I.C., Jessup W., Hill A.F., Garner B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J. Biol. Chem. 2007, 282:2851-2861.
69. Klucken J., Buchler C., Orso E., Kaminski W.E., Porsch-Ozcurumez M., Liebisch G., Kapinsky M., Diederich W., Drobnik W., Dean M., Allikmets R., Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. USA 2000, 97:817-822.
70. Koldamova R.P., Lefterov I.M., Staufenbiel M., Wolfe D., Huang S., Glorioso J.C., Walter M., Roth M.G., Lazo J.S. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 2005, 280:4079-4088.
71. Kwon H.J., Abi-Mosleh L., Wang M.L., Deisenhofer J., Goldstein J.L., Brown M.S., Infante R.E. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 2009, 137:1213-1224.
72. Laffitte B.A., Joseph S.B., Chen M., Castrillo A., Repa J., Wilpitz D., Mangelsdorf D., Tontonoz P. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 2003, 23:2182-2191.
73. Laffitte B.A., Joseph S.B., Walczak R., Pei L., Wilpitz D.C., Collins J.L., Tontonoz P. Autoregulation of the human liver X receptor alpha promoter. Mol. Cell. Biol. 2001, 21:7558-7568.
74. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 2001, 98:507-512.
75. Lange Y., Ory D.S., Ye J., Lanier M.H., Hsu F.F., Steck T.L. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 2008, 283:1445-1455.
76. Lee S., Lee J., Lee S.K., Lee J.W. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. Mol. Endocrinol. 2008, 22:1312-1319.
77. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 1997, 272:3137-3140.
78. Liang Y., Lin S., Beyer T.P., Zhang Y., Wu X., Bales K.R., DeMattos R.B., May P.C., Li S.D., Jiang X.C., Eacho P.I., Cao G., Paul S.M. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 2004, 88:623-634.
79. Lin Y.Y., Smith L.L. Sterol metabolism. 28. Biosynthesis and accumulation of cholest-5-ene-3beta, 24-diol (cerebrosterol) in developing rat brain. Biochim. Biophys. Acta 1974, 348:189-196.
80. Lund E., Bjorkhem I., Furster C., Wikvall K. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta 1993, 1166:177-182.
81. Lund E.G., Guileyardo J.M., Russell D.W. CDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 1999, 96:7238-7243.
82. Lund E.G., Kerr T.A., Sakai J., Li W.P., Russell D.W. CDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 1998, 273:34316-34327.
83. Lund-Katz S., Phillips M.C. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 2010, 51:183-227.
84. Mak P.A., Laffitte B.A., Desrumaux C., Joseph S.B., Curtiss L.K., Mangelsdorf D.J., Tontonoz P., Edwards P.A. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J. Biol. Chem. 2002, 277:31900-31908.
85. Malerod L., Juvet L.K., Hanssen-Bauer A., Eskild W., Berg T. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem. Biophys. Res. Commun. 2002, 299:916-923.
86. Maxfield F.R., Wustner D. Intracellular cholesterol transport. J. Clin. Invest. 2002, 110:891-898.
87. Meaney S., Bodin K., Diczfalusy U., Bjorkhem I. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J. Lipid Res. 2002, 43:2130-2135.
88. Mellon S.H., Deschepper C.F. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 1993, 629:283-292.
89. Mellon S.H., Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends. Endocrinol. Metabol. 2002, 13:35-43.
90. Miller W.L. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim. Biophys. Acta 2007, 1771:663-676.
91. Moghadasian M.H., Salen G., Frohlich J.J., Scudamore C.H. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch. Neurol. 2002, 59:527-529.
92. Morales A., Cuellar A., Ramirez J., Vilchis F., Diaz-Sanchez V. Synthesis of steroids in pancreas: evidence of cytochrome P-450scc activity. Pancreas 1999, 19:39-44.
93. Oftebro H., Bjorkhem I., Skrede S., Schreiner A., Pederson J.I. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J. Clin. Invest. 1980, 65:1418-1430.
94. Ohsaki Y., Cheng J., Suzuki M., Shinohara Y., Fujita A., Fujimoto T. Biogenesis of cytoplasmic lipid droplets: from the lipid ester globule in the membrane to the visible structure. Biochim. Biophys. Acta 2009, 1791:399-407.
95. Olofsson S.O., Bostrom P., Andersson L., Rutberg M., Perman J., Boren J. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim. Biophys. Acta 2009, 1791:448-458.
96. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 2005, 85:1343-1372.
97. Ouimet M., Wang M.D., Cadotte N., Ho K., Marcel Y.L. Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux. Arterioscler. Thromb. Vac. Biol. 2008, 28:1144-1150.
98. Panini S.R., Sexton R.C., Rudney H. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by oxysterol by-products of cholesterol biosynthesis. Possible mediators of low density lipoprotein action. J. Biol. Chem. 1984, 259:7767-7771.
99. Park S.S., Choi H., Kim S.J., Kim O.J., Chae K.S., Kim E. FXRalpha down-regulates LXRalpha signaling at the CETP promoter via a common element. Mol. Cells 2008, 26:409-414.
100. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998, 93:693-704.
101. Pentchev P.G., Comly M.E., Kruth H.S., Tokoro T., Butler J., Sokol J., Filling-Katz M., Quirk J.M., Marshall D.C., Patel S., et al. Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J. 1987, 1:40-45.
102. Peri A., Danza G., Benvenuti S., Luciani P., Deledda C., Rosati F., Cellai I., Serio M. New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm. Front. Neuroendocrinol. 2009, 30:119-129.
103. Pommier A.J., Alves G., Viennois E., Bernard S., Communal Y., Sion B., Marceau G., Damon C., Mouzat K., Caira F., Baron S., Lobaccaro J.M. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010, 29:2712-2723.
104. Potkin B.N., Hoeg J.M., Connor W.E., Salen G., Quyyumi A.A., Brush J.E., Roberts W.C., Brewer H.B. Aneurysmal coronary artery disease in cerebrotendinous xanthomatosis. Am. J. Cardiol. 1988, 61:1150-1152.
105. Prinz W.A. Lipid trafficking sans vesicles: where, why, how?. Cell 2010, 143:870-874.
106. Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA 2007, 104:6511-6518.
107. Ravid T., Doolman R., Avner R., Harats D., Roitelman J. The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 2000, 275:35840-35847.
108. Repa J.J., Berge K.E., Pomajzl C., Richardson J.A., Hobbs H., Mangelsdorf D.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 2002, 277:18793-18800.
109. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., Shan B., Brown M.S., Goldstein J.L., Mangelsdorf D.J. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors. LXRalpha and LXRbeta. Genes Dev. 2000, 14:2819-2830.
110. Rodriguez-Agudo D., Ren S., Wong E., Marques D., Redford K., Gil G., Hylemon P., Pandak W.M. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J. Lipid Res. 2008, 49:1409-1419.
111. Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 1999, 40:781-796.
112. Rowe A.H., Argmann C.A., Edwards J.Y., Sawyez C.G., Morand O.H., Hegele R.A., Huff M.W. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ. Res. 2003, 93:717-725.
113. Russell D.W. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 2000, 1529:126-135.
114. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
115. Sabol S.L., Brewer H.B., Santamarina-Fojo S. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J. Lipid Res. 2005, 46:2151-2167.
116. Salen G. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. Ann. Intern. Med. 1971, 75:843-851.
117. Sanne J.L., Krueger K.E. Expression of cytochrome P450 side-chain cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J. Neurochem. 1995, 65:528-536.
118. Schoenheimer R. Synthesis and destruction of cholesterol in the organism. J. Biol. Chem. 1933, 103:439-448.
119. Schroepfer G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 2000, 80:361-554.
120. Schuster G.U., Parini P., Wang L., Alberti S., Steffensen K.R., Hansson G.K., Angelin B., Gustafsson J.A. Accumulation of foam cells in liver X receptor-deficient mice. Circulation 2002, 106:1147-1153.
121. Schwartz K., Lawn R.M., Wade D.P. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 2000, 274:794-802.
122. Segev H., Reshef A., Clavey V., Delbart C., Routier G., Leitersdorf E. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family. Hum. Genet. 1995, 95:238-240.
123. Shanahan C.M., Carpenter K.L., Cary N.R. A potential role for sterol 27-hydroxylase in atherogenesis. Atherosclerosis 2001, 154:269-276.
124. Shefer S., Hauser S., Salen G., Zaki F.G., Bullock J., Salgado E., Shevitz J. Comparative effects of cholestanol and cholesterol on hepatic sterol and bile acid metabolism in the rat. J. Clin. Invest. 1984, 74:1773-1781.
125. Soccio R.E., Breslow J.L. Intracellular cholesterol transport. Arterioscler. Thromb. Vac. Biol. 2004, 24:1150-1160.
126. Song B.L., Javitt N.B., DeBose-Boyd R.A. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 2005, 1:179-189.
127. Song C., Liao S. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology 2000, 141:4180-4184.
128. Spencer T.A., Gayen A.K., Phirwa S., Nelson J.A., Taylor F.R., Kandutsch A.A., Erickson S.K. 24(S),25-Epoxycholesterol. Evidence consistent with a role in the regulation of hepatic cholesterogenesis. J. Biol. Chem. 1985, 260:13391-13394.
129. Stevenson J., Brown A.J. How essential is cholesterol?. Biochem. J. 2009, 420:e1-e4.
130. Storch J., Xu Z. Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking. Biochim. Biophys. Acta 2009, 1791:671-678.
131. Svensson S., Ostberg T., Jacobsson M., Norstrom C., Stefansson K., Hallen D., Johansson I.C., Zachrisson K., Ogg D., Jendeberg L. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J. 2003, 22:4625-4633.
132. Tajima T., Fujieda K., Kouda N., Nakae J., Miller W.L. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46, XY sex reversal and adrenal insufficiency. J. Clin. Endocrinol. Metab. 2001, 86:3820-3825.
133. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 2008, 7:365-375.
134. Tam S.P., Mok L., Chimini G., Vasa M., Deeley R.G. ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells. Am. J. Physiol. 2006, 291:C490-C502.
135. Tanaka R.D., Li A.C., Fogelman A.M., Edwards P.A. Inhibition of lysosomal protein degradation inhibits the basal degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Lipid Res. 1986, 27:261-273.
136. Tang C.K., Yi G.H., Yang J.H., Liu L.S., Wang Z., Ruan C.G., Yang Y.Z. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages. Acta Pharm. Sinic. 2004, 25:581-586.
137. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R., Laffitte B.A., Daige C.L., Thomas D., Heyman R.A., Mangelsdorf D.J., Wang X., Lusis A.J., Tontonoz P., Schulman I.G. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA 2002, 99:11896-11901.
138. Taylor J.M., Borthwick F., Bartholomew C., Graham A. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. Cardiovasc. Res. 2010, 86:526-534.
139. Thiboutot D., Jabara S., McAllister J.M., Sivarajah A., Gilliland K., Cong Z., Clawson G. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J. Invest. Dermatol. 2003, 120:905-914.
140. Tint G.S., Salen G. Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis. J. Lipid Res. 1982, 23:597-603.
141. Tontonoz P., Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 2003, 17:985-993.
142. Ulven S.M., Dalen K.T., Gustafsson J.A., Nebb H.I. LXR is crucial in lipid metabolism. Prostaglandins, Leukot. Essent. Fatty Acids 2005, 73:59-63.
143. Venkateswaran A., Repa J.J., Lobaccaro J.M., Bronson A., Mangelsdorf D.J., Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 2000, 275:14700-14707.
144. Villablanca E.J., Raccosta L., Zhou D., Fontana R., Maggioni D., Negro A., Sanvito F., Ponzoni M., Valentinis B., Bregni M., Prinetti A., Steffensen K.R., Sonnino S., Gustafsson J.A., Doglioni C., Bordignon C., Traversari C., Russo V. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 2010, 16:98-105.
145. von Bahr S., Movin T., Papadogiannakis N., Pikuleva I., Ronnow P., Diczfalusy U., Bjorkhem I. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). Arterioscler. Thromb. Vac. Biol. 2002, 22:1129-1135.
146. Wang Y., Rogers P.M., Su C., Varga G., Stayrook K.R., Burris T.P. Regulation of cholesterologenesis by the oxysterol receptor. LXRalpha. J. Biol. Chem. 2008, 283:26332-26339.
147. Waterman M.R., Simpson E.R. Regulation of steroid hydroxylase gene expression is multifactorial in nature. Recent Prog. Horm. Res. 1989, 45:533-563. (Discussion 563-536).
148. Whitney K.D., Watson M.A., Goodwin B., Galardi C.M., Maglich J.M., Wilson J.G., Willson T.M., Collins J.L., Kliewer S.A. Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. J. Biol. Chem. 2001, 276:43509-43515.
149. Wikvall K. Hydroxylations in biosynthesis of bile acids. Isolation of a cytochrome P-450 from rabbit liver mitochondria catalyzing 26-hydroxylation of C27-steroids. J. Biol. Chem. 1984, 259:3800-3804.
150. Willy P.J., Mangelsdorf D.J. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 1997, 11:289-298.
151. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995, 9:1033-1045.
152. Wolthers B.G., van der Molen J.C., Walrecht H., Hesselmans L.F. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid. Clin. Chim. Acta 1990, 193:113-118.
153. Wong J., Quinn C.M., Brown A.J. Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux. Arterioscler. Thromb. Vac. Biol. 2004, 24:2365-2371.
154. Wong J., Quinn C.M., Guillemin G., Brown A.J. Primary human astrocytes produce 24(S), 25-epoxycholesterol with implications for brain cholesterol homeostasis. J. Neurochem. 2007, 103:1764-1773.
155. Wong J., Quinn C.M., Gelissen I.C., Brown A.J. Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J. Biol. Chem. 2008, 283:700-707.
156. Xu L., Bai Q., Rodriguez-Agudo D., Hylemon P.B., Heuman D.M., Pandak W.M., Ren S. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate. Lipids 2010, 45:821-832.
157. Yang C., McDonald J.G., Patel A., Zhang Y., Umetani M., Xu F., Westover E.J., Covey D.F., Mangelsdorf D.J., Cohen J.C., Hobbs H.H. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J. Biol. Chem. 2006, 281:27816-27826.
158. Young M.J., Clyne C.D., Cole T.J., Funder J.W. Cardiac steroidogenesis in the normal and failing heart. J. Clin. Endocrinol. Metab. 2001, 86:5121-5126.
159. Yu L., York J., von Bergmann K., Lutjohann D., Cohen J.C., Hobbs H.H. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J. Biol. Chem. 2003, 278:15565-15570.
160. Zelcer N., Hong C., Boyadjian R., Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325:100-104.
161. Zhang M., Liu P., Dwyer N.K., Christenson L.K., Fujimoto T., Martinez F., Comly M., Hanover J.A., Blanchette-Mackie E.J., Strauss J.F. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J. Biol. Chem. 2002, 277:33300-33310.
162. Zhang Y., Repa J.J., Gauthier K., Mangelsdorf D.J. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J. Biol. Chem. 2001, 276:43018-43024.